Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

House GOP unveils healthcare plan ahead of vote next week as cost hike looms for millions

by admin December 13, 2025
December 13, 2025
House GOP unveils healthcare plan ahead of vote next week as cost hike looms for millions

House Republicans have released a 111-page plan for reforming healthcare that they hope to vote on next week.

House GOP leadership aides also told reporters on Friday afternoon that they expected a vote on extending enhanced Obamacare subsidies to also happen next week as part of the amendment process to the final bill, called the ‘Lower Health Care Premiums for All Americans Act.’ The subsidies have been the subject of fierce inter-party debate for Republicans.

‘We expect that there will be an amendment that I believe is being worked on, so the process will allow for that amendment,’ aides said.

The plan as-is includes provisions to codify association health plans, which allow small businesses and people who are self-employed to band together to purchase healthcare coverage plans, giving them access to greater bargaining power.

Republicans also plan to appropriate funding for cost-sharing reductions beginning in 2027, which are designed to lower out-of-pocket medical costs in the individual healthcare market. House GOP leadership aides said it would bring down the cost of premiums by 12%.

New transparency requirements for pharmacy benefit managers (PBMs) are also in the legislation, aimed at forcing PBMs to be more upfront about costs to employers.

PBMs are third parties that act as intermediaries between pharmaceutical companies and those responsible for insurance coverage, often responsible for administrative tasks and negotiating drug prices.

PBMs have also been the subject of bipartisan ire in Congress, with both Republicans and Democrats accusing them of being part of a broken system to inflate health costs.

But the most divisive measure for Republicans is likely not yet fleshed out. 

A majority of House Republicans are against extending the enhanced Obamacare subsidies, which were designed to get affordable health insurance for more Americans during the COVID-19 pandemic.

Democrats voted to pass the enhanced subsidies in 2021 and extended them through 2022 when they controlled Congress.

A group of moderate House Republicans has joined Democrats now in vehemently pushing for those subsidies to be extended again, as millions of Americans face near-certain healthcare price hikes beginning in January.

Two separate bipartisan efforts have been launched to force a vote on extending the subsidies in some form. But any such push would require support from virtually all House Democrats to succeed, and their leaders have not given their blessing to either plan.

‘We’re going to evaluate every single good faith proposal. But it has to meaningfully provide certainty to the American people who are at risk of having their health care ripped away from them,’ House Minority Leader Hakeem Jeffries, D-N.Y., told reporters on Friday.

But conservatives have warned they would not support any such extension unless paired with significant reforms to what they view as a long-broken system that fuels healthcare price inflation.

‘I think that would be a disastrous plan. I mean, we’ve clearly seen that Obamacare is the Titanic. It’s going down. I think throwing money after it is just going to be wasteful,’ House Freedom Caucus member Rep. Eric Burlison, R-Mo., told Fox News’ Chad Pergram on Friday.

This post appeared first on FOX NEWS

previous post
Cruz says Rep Ilhan Omar could face jail time, deportation if marriage allegation proves true
next post
Preservation group sues Trump administration over White House ballroom project

Related Posts

White House slams House Dems releasing Epstein photos...

December 13, 2025

DAVID MARCUS: How Chuck Schumer finally reaped the...

November 15, 2025

GOP senator calls Mamdani’s Netanyahu arrest vow a...

November 25, 2025

Trump administration torpedoes SCOTUS with emergency requests and...

July 4, 2025

Biden-appointed judge blocks Trump’s move to only allow...

June 18, 2025

Poll position: How Trump’s approval rating compares to...

April 19, 2025

Starmer says UK to recognize Palestinian state if...

July 30, 2025

Chief Justice John Roberts pauses judge’s order for...

February 27, 2025

Department of Justice freezes all civil rights division...

January 23, 2025

Conservatives flip script on Senate Dems pushing identical...

March 5, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved